Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-696.19%
operating margin TTM
-690.45%
revenue TTM
49.71 Million
revenue per share TTM
1.77$
valuation ratios | |
|---|---|
| pe ratio | -0.00 |
| peg ratio | -0.00 |
| price to book ratio | -0.00 |
| price to sales ratio | 0.00 |
| enterprise value multiple | 0.77 |
| price fair value | -0.00 |
profitability ratios | |
|---|---|
| gross profit margin | -113.58% |
| operating profit margin | -690.45% |
| pretax profit margin | -696.19% |
| net profit margin | -696.19% |
| return on assets | -143.91% |
| return on equity | 147.27% |
| return on capital employed | 232.56% |
liquidity ratios | |
|---|---|
| current ratio | 0.45 |
| quick ratio | 0.36 |
| cash ratio | 0.28 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 114.49 |
| operating cycle | 186.55 |
| days of payables outstanding | 36.28 |
| cash conversion cycle | 150.27 |
| receivables turnover | 5.07 |
| payables turnover | 10.06 |
| inventory turnover | 3.19 |
debt and solvency ratios | |
|---|---|
| debt ratio | 1.42 |
| debt equity ratio | -1.77 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 2.31 |
| interest coverage | -9.30 |
| cash flow to debt ratio | -0.97 |
cash flow ratios | |
|---|---|
| free cash flow per share | -18.52 |
| cash per share | 6.01 |
| operating cash flow per share | -18.44 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.97 |
| short term coverage ratios | -1.17 |
| capital expenditure coverage ratio | -250.71 |
Frequently Asked Questions
When was the last time T2 Biosystems, Inc. (NASDAQ:TTOO) reported earnings?
T2 Biosystems, Inc. (TTOO) published its most recent earnings results on 14-11-2024.
What is T2 Biosystems, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. T2 Biosystems, Inc. (NASDAQ:TTOO)'s trailing twelve months ROE is 147.27%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. T2 Biosystems, Inc. (TTOO) currently has a ROA of -143.91%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TTOO's net profit margin stand at?
TTOO reported a profit margin of -696.19% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TTOO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.45 in the most recent quarter. The quick ratio stood at 0.36, with a Debt/Eq ratio of -1.77.